Hepatitis C infection and psychiatric burden in two imprisoned cohorts: Young offenders and opioid-maintained prisoners |
| |
| Institution: | 1. Medical University of Vienna, Center for Public Health, Vienna, Austria;2. University of Vienna, Department for Applied Psychology: Work, Education and Economy, Vienna, Austria;1. Villa 7, Compound 26, 2c street, Al Safa 2, DUBAI/ EAU, Spain;2. Rosario Pino 8, 2-C, Madrid, 28020, Spain;3. Andalusian School of Public Health, Instituto de Investigación Biosanitaria (ibs. Granada), Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain;1. Department of Community Health Nursing, Division of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, Japan;2. Department of Gerontological Home Care and Long-Term Care Nursing, Division of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, Japan;3. Cancer Institute Hospital of Japanese Foundation for Cancer Research, Japan;1. Karl Polanyi Institute of Political Economy, Concordia University, Montreal, Canada;2. School of Public Policy and Administration, Carleton University (RH-5224), 1125 Colonel By Drive, Ottawa, Ontario, K1S 5B6, Canada;1. Department of Environmental Sciences, Vytautas Magnus University, Vileikos st. 8, LT-44404, Kaunas, Lithuania;2. Department of Drug Technology and Social Pharmacy, Lithuanian University of Health Sciences, Sukileliu str. 13, LT-50161, Kaunas, Lithuania |
| |
| Abstract: | Prisoners constitute a considerable gap in the hepatitis C virus (HCV) tested population. The present study examined HCV prevalence in imprisoned opioid-maintained patients (OMT-P) and adolescents and young adults (AYA, 14–26 years). In addition, HCV testing and treatment provision, knowledge of HCV status and psychiatric comorbidity were assessed. Data collection took place in six Austrian prisons. Participants were N = 133 for OMT-P (78% male, mean age 35.7 years) and N = 71 for AYA (100% male, mean age 19.8 years). Analysis of HCV serology was conducted. Psychiatric comorbidity and addiction severity were assessed applying standardized questionnaires and interviews. Antibodies were detected in 74.4% of OMT-P, and in 45.0% HCV infection was confirmed. Only one AYA was infected with HCV. None of the participants was receiving treatment for HCV. Eleven percent of OMT-P (50.7% of AYA) did not know their HCV status, and 14.3% of OMT-P (36.6% of AYA) had not been tested in prison. Among OMT-P, lifetime IDU OR = 330.33, CI = 25.91–4433.20] and age at first IDU OR = 0.90, CI = 0.82–0.98] significantly predicted HCV status. In both samples, a high prevalence of affective disorders was observed. Despite the high prevalence of HCV among opioid-dependent detainees, the unique opportunities for comprehensive testing and treatment of HCV are substantially underutilized. This is in stark contrast to the UN Basic Principles for the Treatment of Prisoners. |
| |
| Keywords: | Hepatitis C Prevalence Prison Opioid maintenance treatment Psychiatric burden |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
